Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...

How likely is it for President Trump's new drug-pricing plan to be implemented? And will we see a return of Elizabeth Holmes' blood-testing ambitions? All that and more on "The Readout LOUD" podcast.

Biotech investors are preparing for what may be the most important clinical trial readout for them this summer.

Development of molecules that target a severe unmet need ...

Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress”), an innovative biopharmaceutical company focused on acquiring and ...

The company improved its EBITDA margin by 500 basis points year-on-year in FY25, while its net debt-to-EBITDA ratio declined ...

The Garden State is looking to grow into the next big biotech hub. | The Garden State is looking to grow into the next big ...

The Crispr therapy was tailored to the baby’s specific condition and could provide a template for others.

Enliven Therapeutics has decided against taking its phase 1-stage solid tumor drug into further development next year in ...

The one-off treatment highlights the promise of a new type of gene editing and the challenges of using it to treat extremely ...

Biotech firm NTxBio is establishing a facility in Plano, promising over 170 new jobs and a $31 million investment.

RFK Jr., Trump, and Republicans want AI to fill the gaps as they move to throw millions off Medicaid, gut funding for ...